These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9052371)

  • 1. Effectiveness of cardiac transplantation for primary (AL) cardiac amyloidosis.
    Pelosi F; Capehart J; Roberts WC
    Am J Cardiol; 1997 Feb; 79(4):532-5. PubMed ID: 9052371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis.
    Sack FU; Kristen A; Goldschmidt H; Schnabel PA; Dengler T; Koch A; Karck M
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):257-62. PubMed ID: 18096396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cardiac amyloidosis with 20-year survival.
    Fealey ME; Edwards WD; Grogan M; Dispenzieri A
    Cardiovasc Pathol; 2006; 15(6):331-5. PubMed ID: 17113011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of cardiac diastolic function and prognosis after autologous peripheral blood stem cell transplantation in AL cardiac amyloidosis.
    Yagi S; Akaike M; Ozaki S; Moriya C; Takeuchi K; Hara T; Fujimura M; Sumitomo Y; Iwase T; Ikeda Y; Aihara K; Kimura T; Nishiuchi T; Abe M; Matsumoto T
    Intern Med; 2007; 46(20):1705-10. PubMed ID: 17938525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis.
    Mueller PS; Edwards WD; Gertz MA
    Am J Med; 2000 Aug; 109(3):181-8. PubMed ID: 10974179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of electrocardiographic findings in patients with AL (primary) amyloidosis and in familial amyloid polyneuropathy and anginal pain and their relation to histopathologic findings.
    Hongo M; Yamamoto H; Kohda T; Takeda M; Kinoshita O; Uchikawa S; Imamura H; Kubo K
    Am J Cardiol; 2000 Apr; 85(7):849-53. PubMed ID: 10758925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of the cardiac amyloidoses.
    Falk RH
    Circulation; 2005 Sep; 112(13):2047-60. PubMed ID: 16186440
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac manifestations of amyloid disease.
    Rivera RJ; Vicenty S
    Bol Asoc Med P R; 2008; 100(4):60-70. PubMed ID: 19400531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac amyloidosis: the importance of a multidisciplinary approach.
    Gómez-Bueno M; Segovia J; García-Pavía P; Barceló JM; Krsnik I; Sánchez-Turrión V; Salas C; Alonso-Pulpón L
    Rev Esp Cardiol; 2009 Jun; 62(6):698-702. PubMed ID: 19480768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
    Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
    Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The return of the normal heart: resolution of cardiac amyloidosis after chemotherapy and bone marrow transplantation.
    Fitzgerald BT; Bashford J; Scalia GM
    Heart Lung Circ; 2013 Aug; 22(8):655-60. PubMed ID: 23474152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of histopathologic patterns of cardiac amyloidosis.
    Smith TJ; Kyle RA; Lie JT
    Mayo Clin Proc; 1984 Aug; 59(8):547-55. PubMed ID: 6748745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical problem of occult cardiac amyloidosis. Forensic implications.
    Petersen EC; Engel JA; Radio SJ; Canfield TM; McManus BM
    Am J Forensic Med Pathol; 1992 Sep; 13(3):225-9. PubMed ID: 1476128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantation of a cardioverter-defibrillator in a patient with cardiac amyloidosis.
    Wright BL; Grace AA; Goodman HJ
    Nat Clin Pract Cardiovasc Med; 2006 Feb; 3(2):110-4; quiz 115. PubMed ID: 16446780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart transplantation and cardiac amyloidosis: approach to screening and novel management strategies.
    Varr BC; Liedtke M; Arai S; Lafayette RA; Schrier SL; Witteles RM
    J Heart Lung Transplant; 2012 Mar; 31(3):325-31. PubMed ID: 22051505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis of autologous stem cell transplantation for nine cases of cardiac amyloidosis].
    Ogura M; Sekine R; Nishiyama S; Abe Y; Iizuka H; Kusaka S; Nakagawa Y; Suzuki K
    Rinsho Ketsueki; 2012 Jul; 53(7):710-5. PubMed ID: 22975774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current perspectives on cardiac amyloidosis.
    Guan J; Mishra S; Falk RH; Liao R
    Am J Physiol Heart Circ Physiol; 2012 Feb; 302(3):H544-52. PubMed ID: 22058156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis.
    Varr BC; Zarafshar S; Coakley T; Liedtke M; Lafayette RA; Arai S; Schrier SL; Witteles RM
    Heart Rhythm; 2014 Jan; 11(1):158-62. PubMed ID: 24121001
    [No Abstract]   [Full Text] [Related]  

  • 19. Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia.
    Hashimura H; Ishibashi-Ueda H; Yonemoto Y; Ohta-Ogo K; Matsuyama TA; Ikeda Y; Morita Y; Yamada N; Yasui H; Naito H
    Heart Vessels; 2016 Jun; 31(6):990-5. PubMed ID: 25794983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart transplantation in primary amyloidosis.
    Baumgratz JF; Vila JH; Guilhen CJ; Fonseca Ld; Leite WF; D'Andretta C; Tângari Junior A; Silva JP
    Rev Bras Cir Cardiovasc; 2009; 24(3):409-12. PubMed ID: 20011892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.